Internal restructuring
European Union
Location of affected unit(s)
Belgium, Spain, Sweden, UK
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

1,400 jobs
Number of planned job losses
Job loss
Announcement Date
20 November 2008
Employment effect (start)
Foreseen end date
31 December 2013


AstraZeneca, a Anglo-Swedish pharmaceutical company, has announced that it is to cut 1,400 jobs by 2013 and to close three European factories located in Belgium, Spain and Sweden. 250 job losses are also expected in the UK at the company's site in Macclesfield. Just over 1,050 of the job cuts will occur by 2010 with the remainder, mainly positions in Sweden, made between 2010 and 2013. A company's spokesman said that "these moves are a continuation of AstraZeneca's programme to improve the organisation's productivity and efficiency".



Eurofound (2008), Astra Zeneca, Internal restructuring in European Union, factsheet number 68046, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/68046.